Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wu X et al. – Chemotherapy induces temporary immune reconstitution and augments anti–tumor immune response. It is probable that the “window” period of days 12–14 after chemotherapy provides the best opportunity for immunotherapy.

Related Articles

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09    Relevance Score: 72%

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09    Relevance Score: 70%

Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09    Relevance Score: 70%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 70%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09    Relevance Score: 70%

Today in Clinical Pharmacology...keeping you current

Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09

Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09

Endometrial Cancer in Postmenopausal Women Using Estradiol-Progestin Therapy
Obstetrics and Gynecology, 12/01/09

Today in Gynecologic Oncology...keeping you current

Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09

Vaginal Schwannoma in a case with uterine myoma
Annals of Diagnostic Pathology, 12/04/09

Clinical management of uterine sarcomas
The Lancet Oncology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address